Trials / Completed
CompletedNCT02969304
Study of Utilization Patterns of Dimethyl Fumarate in Germany
Claims Database Study of Utilization Patterns of Dimethyl Fumarate in Germany
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 930 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to estimate the proportion of DMF use that is prescribed "on-label" versus "off-label". The secondary objectives are: To describe the demographic characteristics and medical history of DMF users; To describe prescription drug history and concomitant medication use of DMF users; To describe the duration of therapy in participants newly initiating DMF treatment; To describe the medical specialties of DMF prescribers.
Detailed description
Dimethyl fumarate will not be provided to participants as a part of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dimethyl fumarate | Off-Label Use: All participants \<18 years of age and participants without an MS diagnosis who are prescribed dimethyl fumarate On-Label Use: All participants \>18 years of age with an MS diagnosis who are prescribed dimethyl fumarate |
Timeline
- Start date
- 2016-12-30
- Primary completion
- 2017-03-02
- Completion
- 2017-03-02
- First posted
- 2016-11-21
- Last updated
- 2017-07-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02969304. Inclusion in this directory is not an endorsement.